Correspondence | Published:

Read and assembly metrics inconsequential for clinical utility of whole-genome sequencing in mapping outbreaks

Nature Biotechnology volume 31, pages 592594 (2013) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Accessions

European Nucleotide Archive

References

  1. 1.

    et al. Nat. Biotechnol. 30, 434–439 (2012).

  2. 2.

    et al. BMJ Open 2, e001124 (2012).

  3. 3.

    et al. N. Engl. J. Med. 364, 730–739 (2011).

  4. 4.

    et al. Lancet Infect. Dis., 13, 130–136 (2012).

  5. 5.

    et al. PLoS Pathog. 8, e1002824 (2012).

  6. 6.

    et al. N. Engl. J. Med. 366, 2267–2275 (2012).

  7. 7.

    et al. Sci. Transl. Med. 4, 148ra116 (2012).

  8. 8.

    et al. BMC Genomics 13, 341 (2012).

  9. 9.

    et al. J. Clin. Microbiol. 51, 611–614 (2012).

  10. 10.

    et al. Genome Res. 20, 1297–1303 (2010).

  11. 11.

    et al. Bioinformatics 25, 2078–2079 (2009).

  12. 12.

    Bioinformatics 22, 2688–2690 (2006).

Download references

Author information

Affiliations

  1. Wellcome Trust Sanger Institute, Hinxton, UK.

    • Simon R Harris
    • , Michael A Quail
    • , Sharon J Peacock
    •  & Julian Parkhill
  2. University of Cambridge, Cambridge, UK.

    • M E Török
    • , Edward J P Cartwright
    •  & Sharon J Peacock
  3. Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

    • M E Török
    • , Edward J P Cartwright
    •  & Sharon J Peacock
  4. Public Health England, Cambridge, UK.

    • M E Török
    • , Edward J P Cartwright
    •  & Sharon J Peacock

Authors

  1. Search for Simon R Harris in:

  2. Search for M E Török in:

  3. Search for Edward J P Cartwright in:

  4. Search for Michael A Quail in:

  5. Search for Sharon J Peacock in:

  6. Search for Julian Parkhill in:

Competing interests

J.P. has received funding for conference travel and accommodations from Pacific Biosciences and Illumina. S.J.P. is a consultant for Pfizer.

Corresponding author

Correspondence to Julian Parkhill.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Table 1

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.2616

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing